Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 237-246

  Said, Harun M ^a   Stein, Susanne ^b   Hagemann, Carsten ^a   Polat, Buelent ^a   Staab, Adrian ^a,e   Anacker, Jelena ^a   Schoemig, Beate ^a   Theobald, Matthias ^b,c   Flentje, Michael ^a   Vordermark, Dirk ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Astrocytoma; Glioblastoma; Glycolysis inhibitor; HIF 1 ; Hypoxia reponsive element; Iodide acetate; NDRG1; Oxygen; Tumor hypoxia

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; IODOACETIC ACID; MESSENGER RNA; N MYC DOWNREGULATED PROTEIN 1; OXYGEN; PROTEIN NDRG1; SMALL INTERFERING RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; HIF1A PROTEIN, HUMAN; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; N-MYC DOWNSTREAM-REGULATED GENE 1 PROTEIN; SIGNAL PEPTIDE;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN TUMOR; CELL HYPOXIA; GENE EXPRESSION; METABOLISM; NORTHERN BLOTTING; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, NORTHERN; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OXYGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 61449494795     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000214     Document Type: Article

References (51)

1. Brown JM: Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 6: 157-162, 2000.
2. Kallio PJ, Pongratz I, Gradin K, et al: Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA 94: 5667-5672, 1997.
3. Richard DE, Berra E and Pouyssegur J: Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 266: 718-722, 1999.
4. Guppy M: The hypoxic core: a possible answer to the cancer paradox. Biochem Biophys Res Commun 299: 676-680, 2002.
5. Qu X, Zhai Y, Wei H, et al: Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229: 35-44, 2002.
6. Angst E, Sibold S, Tiffon C, et al: Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer 95: 307-313, 2006.
7. Piquemal D, Joulia D and Commes T: Transforming growth factor-β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. Biochim Biophys Acta 1450: 364-373, 1999.
8. Van Belzen N, Dinjens WN, Diesveld MP, et al: A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77: 85-92, 1997.
9. Bandyopadhyay S, Pai SK, Gross SC, et al: The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63: 1731-1736, 2003.
10. Greijer AE, van der Groep P, Kemming D, et al: Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206: 291-304, 2005.
11. Salnikow K, Davidson T, Zhang Q, et al: The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis. Cancer Res 63: 3524-3530, 2003.
12. Lachat P, Shaw P, Gebhard S, et al: Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118: 399-408, 2002.
13. Chen B, Nelson DM and Sadovsky Y: N-Myc downregulated gene 1 (Ndrg1) modulates the response of term human trophoblasts to hypoxic injury. J Biol Chem 281: 2764-2772, 2006.
14. Sibold S, Roh V, Keogh A, et al: Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett 581: 989-994, 2007.
15. Cangul H: Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5: 27, 2004.
16. Han YH, Xia L, Song LP, et al: Comparative proteomic analysis of hypoxia-treated and untreated human leukemic U937 cells. Proteomics 6: 3262-3274, 2007.
17. Stein S, Thomas EK, Herzog B, et al: NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279: 48930-48940, 2004.
18. Ando T, Ishiguro H, Kimura M, et al: Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 19: 454-458, 2006.
19. Akslen LA, Andersen KJ and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-803, 1988.
20. Vordermark D and Brown JM: Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies. Int J Radiat Oncol Biol Phys 56: 1184-1193, 2003.
21. Said HM, Hagemann C, Staab A, et al: Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 83: 398-405, 2007.
22. Dooley S, Said HM, Gressner AM, et al: Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281: 1784-1795, 2006.
23. Said HM, Katzer A, Flentje M, et al: Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol 76: 200-205, 2005.
24. Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553, 2002.
25. Quandt K, Frech F, Karas H, Wingender E and Werner T: MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23: 4878-4884, 1995.
26. Said HM, Hagemann C, Stojic J, et al: GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol 8: 55, 2007.
27. Said HM, Staab A, Hagemann C, et al: Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. J Neurooncol 81: 27-38, 2007.
28. Wakisaka Y, Furuta A, Masuda K, et al: Cellular distribution of NDRG1 protein in the rat kidney and brain during normal postnatal development. J Histochem Cytochem 51: 1515-1525, 2003.
29. Zhou RH, Kokame K, Tsukamoto Y, et al: Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73: 86-97, 2001.
30. Echaniz-Laguna A, Degos B, Bonnet C, et al: NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement. Neuromuscul Disord 17: 163-168, 2007.
31. Choi SJ, Oh SY, Kim JH, et al: Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia. Am J Obstet Gynecol 196: 45.e1-45.e7, 2007.
32. Chen P, Iavarone A, Fick J, et al: Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet 82: 106-115, 1995.
33. Watanabe T, Katayama Y, Yoshino A, et al: Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression. Brain Pathol 17: 5-10, 2007.
34. U HS, Banaie A, Rigby L, et al: Alteration in p53 modulates glial proteins in human glial tumour cells. J Neurooncol 48: 191-206, 2000.
35. Chua MS, Sun H, Cheung ST, et al: Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 1: 76-83, 2007.
36. Cangul H, Salnikow K, Yee H, et al: Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol Toxicol 18: 87-96, 2002.
37. Zagzag D, Zhong H, Scalzitti JM, et al: Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion and progression. Cancer 88: 2606-2618, 2000.
38. Staab A, Löffler J, Said HM, et al: Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1α). Strahlenther Onkol 183: 366-373, 2007.
39. Zhang P, Tchou-Wong KM and Costa M: Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67: 9125-9133, 2007.
40. Ellen T, Ke Q, Zhang P and Costa M: NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29: 2-8, 2008.
41. Semenza GL, Nejfelt MK, Chi SM and Antonarakis SE: Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88: 5680-5684, 1991.
42. Tuschl T: Expanding small RNA interference. Nat Biotechnol 20: 446-448, 2002.
43. Tuschl T and Borkhardt A: Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. Mol Interv 2: 158-167, 2002.
44. Davies H, Bignell GR, Cox C, et al: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
45. Ishii N, Maier D, Merlo A, et al: Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9: 469-479, 1999.
46. Shinoura N, Sakurai S, Shibasaki F, et al: Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas. Br J Cancer 86: 587-595, 2002.
47. Said H, Stein S, Staab A, Katzer A, Flentje M and Vordermark D: NDRG1 is regulated in human glioblastoma in vitro as a consequence to the changing concentrations of the oxygen microenviroment. FEBS J 273: 345, 2006.
48. Said HM, Stein S, Hagemann C, Polat B, Schömig B, Staab A, Theobald M, Flentje M and Vordermark D: NDRG1 regulation as a response to an alternating hypoxic microenviroment in vivo and in vitro in human brain tumors. FEBS J 274: 281, 2007.
49. Park H, Adams MA, Lachat P, et al: Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 276: 321-328, 2000.
50. Ito H, Kanzawa T, Miyoshi T, et al: Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Hum Gene Ther 16: 685-698, 2005.
51. Posch MG, Zang C, Mueller W, et al: Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cells. Med Sci Monit 10: BR250-BR254, 2004.